Akorn Timolol Maleate Ophthalmic Solution, USP, 0.5%, 5 x 0.3 mL Single-Dose Vials recall — FDA D-1471-2022
Failed Impurities/Degradation Specifications: Identification of an unknown impurity at the 12-month stability point.
Complete FDA and NHTSA recall records dated in September 2022.
These records include useful source details for the selected month.
Failed Impurities/Degradation Specifications: Identification of an unknown impurity at the 12-month stability point.
cGMP deviation: Product held outside of appropriate temperature storage conditions.
cGMP deviation: Product held outside of appropriate temperature storage conditions.
Labeling: Not Elsewhere Classified: Carton incorrectly identifies product as doxylamine succinate HCl, however the product is doxylamine succinate.
Nissan North America, Inc. (Nissan) is recalling certain 2020-2023 Titan, 2020-2022 Frontier, and 2023 Z vehicles. The transmission parking pawl may not engage when the vehicle is shifted…
Nissan North America, Inc. (Nissan) is recalling certain 2021-2022 Rogue vehicles. The rear seat belts for the left-hand and right-hand rear seats may not retract properly. As such, these…
Use this page to compare the recalls reported during the month, then open an individual record for the exact reason, classification, company, remedy or distribution information available from the official source. Monthly counts are descriptive, not a safety rating.